The global diabetic retinopathy market size was valued at $3,086.00 million in 2020, and is projected to reach $10,785.50 million by 2030, registering a CAGR of 13.7% from 2021 to 2030.
Diabetic eye disease devices are medical devices used to treat and diagnose renal complications that occur due to diabetes. The most common diabetic eye diseases include diabetic retinopathy, diabetic macular edema, cataract, and glaucoma. These conditions may lead to complete blindness if not treated on time.
Diabetic lancing devices are devices used to obtain samples of blood for glucose testing using a lancet. They are widely used in the diagnostic centers, laboratories, hospitals, clinics, ...
